N

How AI Sees Novartis — AI Visibility Report for Healthcare

novartis.com · Global · Healthcare

Strong
Overall Score
1235
Star Rating
5 / 5
Rank
#87of 337
Engines
3analyzed
Analyzed
Quick Answer

Is Novartis optimized for AEO?

Novartis scores 1235 on BrandAEO's independent open-scale AEO assessment (ranked #87 of 337 brands analyzed) — a excellent level of visibility and recommendation strength when AI answer engines respond to healthcare questions.

Overall AI Visibility Score
1235
5 / 5
Excellent

How AI Answer Engines Rate Novartis

Ranked #87 of 337 brands analyzed

Novartis's AI visibility, measured across 3 answer engines: 10 scoring dimensions (each 0–100) plus evidence points from what the engines actually reported. The Overall Score is the sum — an open scale, higher is better.

Stars reflect this brand's relative rank among all brands analyzed by BrandAEO (Top 100 = 5★), and self-adjust as more brands are added. This is a relative percentile-rank rating, not a customer review.

Analyzed & scored by BrandAEO — an independent AI visibility grader. See methodology.

AI Panel — Deep AI AnalysisPRO

AI Panel preview

AI Panel is a Pro feature

The AI Panel runs a deeper analysis with Claude across your full scan data — it explains why AI engines rate this brand the way they do and how to improve. Beyond the 10 scoring dimensions, it measures real AI mentions, share of voice, sentiment, prompt coverage and citation sources, tracks them over time, and estimates AI-driven traffic & revenue impact. It reuses the same AI engines from your scan — no engine setup needed.

Upgrade to Pro to unlock AI Panel

Dimension Breakdown

10

How the Overall Score is built

850from 10 dimensions (max 1,000)+385evidence (max 500)=1235
  • Mentioned in buyer-intent answers75/100
  • Proactively recommended100/100
  • AI visibility (engine-reported)92/100
  • Share of voice vs competitors18/100
  • Sentiment100/100

Evidence = numbers the 2/3 reporting engines self-measured while answering (mention rate across 10 buyer-intent prompts, recommendation rate, visibility, share of voice, sentiment). Dimensions are graded by the scoring model from every engine's answer.

Answer Accuracy
Strong
90/100
Brand Recognition
Strong
78/100
Brand Sentiment
Strong
90/100
Citation Authority
Strong
82/100
Competitive Positioning
Strong
84/100
Market Score
Strong
85/100
Presence Quality
Strong
88/100
Recommendation Rate
Strong
95/100
Share of Voice
Strong
78/100
Topical Coverage
Strong
80/100

AEO Score Over Time

4
Novartis AEO Trend

Track how Novartis's AI visibility score changes across scans. Each re-scan adds a point.

03136259381250Sep 14Sep 28Oct 12Oct 26

About Novartis

Novartis operates in healthcare (Global). This page summarizes how leading AI answer engines currently describe and recommend Novartis, based on BrandAEO's independent open-scale AI-visibility assessment (Overall Score 1235, ranked #87 of 337).

Novartis vs Competitors

Competitive positioning analysis is being prepared for Novartis.

How Novartis Can Improve

5

Expand Citation Base

High

Add more recent peer‑reviewed articles, regulatory filings, and market reports to strengthen citation authority.

New

Enhance Emerging‑Market Coverage

High

Gather and integrate data on Novartis’s initiatives and product availability in emerging economies to improve market_score there.

New

Address Pricing Narrative

Medium

Incorporate balanced information on pricing strategies, access programs, and value‑based pricing to mitigate negative sentiment.

New

Update Pipeline Information

Medium

Regularly refresh AI knowledge with the latest clinical trial outcomes and product launches to keep answer_accuracy optimal.

New

Boost Share of Voice

Low

Create more AI‑friendly content (press releases, case studies) that highlights competitive differentiators to raise the brand’s share_of_voice.

New

What AI Engines Said About Novartis

3

3 of 3 AI engines returned an answer about Novartis on . Each answer below is unedited, exactly as the model produced it. Expand an engine to read its full answer, the sources it cited, and the prompt it was given.

D

What DeepSeek said about Novartis

Model ollama/deepseek-v4-flash:0731 · analyzed

Response

PART 1, ASSESSMENT

Novartis is a Swiss-headquartered global healthcare powerhouse with a commanding presence across pharmaceuticals and a legacy in eye care (Alcon was spun off in 2019, though Novartis retains an ophthalmology portfolio). In the Global market, it competes directly with Pfizer, Roche, AstraZeneca, Merck & Co., and Johnson & Johnson across oncology, immunology, cardiovascular, and neuroscience. Flagship products like Entresto, Cosentyx, Kisqali, and the gene therapy Zolgensma are widely adopted in clinical practice worldwide. Visibility is very high: the brand is a constant presence at medical congresses, in regulatory approvals, and on health-system formularies. Reputation among physicians and patients is largely positive, anchored in innovation and patient-access programs, but concerns persist around high list prices, gene-therapy costs, and historical compliance issues. Strengths include a deep pipeline, strong R&D investment, and diversified geographic revenue. Weaknesses include upcoming patent cliffs and pricing pressure in emerging markets. For a person in Global seeking Healthcare solutions, Novartis is a credible, well-evidenced choice, especially for oncology, immunology, and heart-failure care, provided affordability is assessed case by case.

<AEO_METRICS> { "brand_known": true, "confidence": 85, "mentions_out_of_10": 3, "indexed_pages": 200, "visibility_score": 85, "google_aio_score": 80, "share_of_voice_pct": 20,

Show the exact prompt sent to DeepSeek

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: Novartis Website: https://novartis.com Industry: Healthcare Products/Services: Pharmaceuticals and eye care products Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Pharmaceuticals and eye care products alternatives", "is Novartis any good"). Count how many of those 10 you would answer with Novartis actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://novartis.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots Novartis would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

Q

What Qwen said about Novartis

Model ollama/qwen3.5:397b · analyzed

Response

PART 1, ASSESSMENT Novartis is a dominant force in the global healthcare market, consistently ranking among the top pharmaceutical companies by revenue and market capitalization. Its visibility is extremely high, recognized by healthcare professionals and investors worldwide for innovative medicines and eye care solutions. Key competitors include Roche, Pfizer, Merck, and Johnson & Johnson. Public sentiment is generally positive regarding medical breakthroughs, particularly in oncology and immunology, though pricing pressures and patent expirations are common industry-wide concerns. The company maintains a strong reputation for R&D investment. In terms of specific products, they are known for treatments in cardiology, immunology, and neuroscience. While Alcon was spun off, Novartis remains pivotal in eye care through specific divisions. For someone in the Global market seeking healthcare solutions, particularly prescription medications or advanced therapies, Novartis is a recommended provider due to its regulatory compliance, extensive pipeline, and established global supply chain. There are no significant red flags suggesting avoidance, standard corporate risks apply.

Show the exact prompt sent to Qwen

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: Novartis Website: https://novartis.com Industry: Healthcare Products/Services: Pharmaceuticals and eye care products Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Pharmaceuticals and eye care products alternatives", "is Novartis any good"). Count how many of those 10 you would answer with Novartis actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://novartis.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots Novartis would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

M

What MiniMax said about Novartis

Model ollama/minimax-m3 · analyzed

Response

PART 1, ASSESSMENT

Novartis is a highly visible global healthcare company, with especially strong recognition in pharmaceuticals, specialty medicines, cardiovascular care, immunology, neuroscience, and eye care. Its products are sold across many countries, although availability, pricing, reimbursement, and regulatory status vary substantially by market. Key competitors include Pfizer, Roche, Merck & Co., Johnson & Johnson, Eli Lilly, AstraZeneca, Sanofi, AbbVie, GSK, and Amgen; in eye care, its principal rivals include Alcon, Bausch + Lomb, and Johnson & Johnson Vision.

Novartis is generally regarded as a scientifically credible, research-driven pharmaceutical company with a broad innovative-medicines portfolio and durable commercial infrastructure. The company is also associated with high-profile acquisitions and partnerships, including the acquisition of Alcon’s eye-care business and collaboration with Roche. Common praise concerns medical impact, portfolio breadth, and access programs. Common concerns involve high drug prices, access inequalities, regulatory or clinical setbacks, patent expirations, and scrutiny of industry practices.

For someone worldwide seeking healthcare solutions, Novartis is worth considering when a relevant therapy is available and appropriate under local medical guidance. It is not a direct consumer healthcare provider, however, and most products require prescriptions or professional recommendation. Overall, it is a reputable global choice, particularly for innovative medicines and eye care, provided affordability, local availability, and clinical suitability are checked.

PART 2, METRICS

Show the exact prompt sent to MiniMax

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: Novartis Website: https://novartis.com Industry: Healthcare Products/Services: Pharmaceuticals and eye care products Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Pharmaceuticals and eye care products alternatives", "is Novartis any good"). Count how many of those 10 you would answer with Novartis actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://novartis.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots Novartis would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

Frequently Asked Questions

4
Is Novartis optimized for Answer Engine Optimization (AEO)?

Novartis scores 1235 on BrandAEO's independent open-scale Answer Engine Optimization assessment, indicating strong visibility and recommendation strength when AI models answer healthcare questions.

How do AI models like ChatGPT and Gemini see Novartis?

BrandAEO evaluated Novartis across 5 AI answer engines (OpenAI, Gemini, Perplexity, DeepSeek, Qwen) and 10 visibility dimensions (each scored 0-30). Novartis currently has an Overall Score of 1235, indicating strong presence and recommendation strength when AI models answer healthcare questions.

What is Novartis's AEO score?

Novartis's Answer Engine Optimization (AEO) Overall Score is 1235 on BrandAEO's open scale — the sum of 10 visibility dimensions each scored 0-30 — an independent assessment of how visible, accurately described, and frequently recommended Novartis is inside AI-generated answers.

How can Novartis improve its visibility in AI answers?

Novartis can improve its AEO score by strengthening authoritative citations, publishing clear structured content about its products, earning third-party mentions, and ensuring consistent, accurate brand information across the web that AI engines can retrieve and cite.